| The nuclear factor-κB pathway controls the progression of prostate cancer to androgen-independent growth RJ Jin, Y Lho, L Connelly, Y Wang, X Yu, L Saint Jean, TC Case, ... Cancer research 68 (16), 6762-6769, 2008 | 226 | 2008 |
| Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation N Gao, K Ishii, J Mirosevich, S Kuwajima, SR Oppenheimer, RL Roberts, ... Oxford University Press for The Company of Biologists Limited 132 (15), 3431 …, 2005 | 201 | 2005 |
| Wnt/β-catenin activation promotes prostate tumor progression in a mouse model X Yu, Y Wang, DJ DeGraff, ML Wills, RJ Matusik Oncogene 30 (16), 1868-1879, 2011 | 149 | 2011 |
| Endothelium-independent effect of estrogen on Ca2+-activated K+ channels in human coronary artery smooth muscle cells RE White, G Han, M Maunz, C Dimitropoulou, AM El-Mowafy, RS Barlow, ... Cardiovascular research 53 (3), 650-661, 2002 | 138 | 2002 |
| Mouse models of prostate cancer: picking the best model for the question MM Grabowska, DJ DeGraff, X Yu, RJ Jin, Z Chen, AD Borowsky, ... Cancer and Metastasis Reviews 33, 377-397, 2014 | 126 | 2014 |
| Activation of β‐Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration X Yu, Y Wang, M Jiang, B Bierie, P Roy‐Burman, MM Shen, MM Taketo, ... The Prostate 69 (3), 249-262, 2009 | 120 | 2009 |
| Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation DJ DeGraff, PE Clark, JM Cates, H Yamashita, VL Robinson, X Yu, ... PloS one 7 (5), e36669, 2012 | 115 | 2012 |
| HS2 Enhancer Function Is Blocked by a Transcriptional Terminator Inserted between the Enhancer and the Promoter*[boxs] J Ling, L Ainol, L Zhang, X Yu, W Pi, D Tuan Journal of Biological Chemistry 279 (49), 51704-51713, 2004 | 110 | 2004 |
| Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially X Yu, A Gupta, Y Wang, K Suzuki, J Mirosevich, MC ORGEBIN‐CRIST, ... Annals of the New York Academy of Sciences 1061 (1), 77-93, 2005 | 104 | 2005 |
| Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression R Jin, H Yamashita, X Yu, J Wang, OE Franco, Y Wang, SW Hayward, ... Oncogene 34 (28), 3700-3710, 2015 | 101 | 2015 |
| NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression MM Grabowska, AD Elliott, DJ DeGraff, PD Anderson, G Anumanthan, ... Molecular endocrinology 28 (6), 949-964, 2014 | 79 | 2014 |
| Disruption of PPARγ signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy M Jiang, S Fernandez, WG Jerome, Y He, X Yu, H Cai, B Boone, Y Yi, ... Cell Death & Differentiation 17 (3), 469-481, 2010 | 69 | 2010 |
| The long terminal repeat (LTR) of ERV-9 human endogenous retrovirus binds to NF-Y in the assembly of an active LTR enhancer complex NF-Y/MZF1/GATA-2 X Yu, X Zhu, W Pi, J Ling, L Ko, Y Takeda, D Tuan Journal of Biological Chemistry 280 (42), 35184-35194, 2005 | 63 | 2005 |
| The LTR enhancer of ERV-9 human endogenous retrovirus is active in oocytes and progenitor cells in transgenic zebrafish and humans W Pi, Z Yang, J Wang, L Ruan, X Yu, J Ling, S Krantz, C Isales, ... Proceedings of the National Academy of Sciences 101 (3), 805-810, 2004 | 61 | 2004 |
| Estrogen receptor α mediates acute potassium channel stimulation in human coronary artery smooth muscle cells G Han, X Yu, L Lu, S Li, H Ma, S Zhu, X Cui, RE White Journal of Pharmacology and Experimental Therapeutics 316 (3), 1025-1030, 2006 | 59 | 2006 |
| Skp2 regulates androgen receptor through ubiquitin‐mediated degradation independent of Akt/mTOR pathways in prostate cancer B Li, W Lu, Q Yang, X Yu, RJ Matusik, Z Chen The Prostate 74 (4), 421-432, 2014 | 57 | 2014 |
| SOX2 expression in the developing, adult, as well as, diseased prostate X Yu, JM Cates, C Morrissey, C You, MM Grabowska, J Zhang, ... Prostate cancer and prostatic diseases 17 (4), 301-309, 2014 | 55 | 2014 |
| FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype DJ DeGraff, MM Grabowska, TC Case, X Yu, MK Herrick, WJ Hayward, ... Laboratory investigation 94 (7), 726-739, 2014 | 50 | 2014 |
| Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors V Singh, PK Jaiswal, I Ghosh, HK Koul, X Yu, A De Benedetti International journal of cancer 145 (4), 1055-1067, 2019 | 47 | 2019 |
| Prostate epithelial cell fate RJ Matusik, RJ Jin, Q Sun, Y Wang, X Yu, A Gupta, S Nandana, TC Case, ... Differentiation 76 (6), 682-698, 2008 | 47 | 2008 |
